Scarica l'app Stockscreener
24.18
0.86%
-0.21
Dopo l'orario di chiusura:
24.04
-0.14
-0.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$24.39
Aprire:
$24.15
Volume 24 ore:
5.63M
Relative Volume:
0.88
Capitalizzazione di mercato:
$12.50B
Reddito:
$11.32B
Utile/perdita netta:
$-981.00M
Rapporto P/E:
-12.38
EPS:
-1.9532
Flusso di cassa netto:
$714.00M
1 W Prestazione:
-5.44%
1M Prestazione:
-12.96%
6M Prestazione:
+38.49%
1 anno Prestazione:
+0.83%
Intervallo 1D:
$23.92
$24.38
Intervallo di 1 settimana:
$23.92
$26.11
Portata 52W:
$15.73
$30.00
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
24.18 | 12.61B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
360.46 | 124.79B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.42 | 48.98B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.55 | 33.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.58 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
32.39 | 29.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-31 | Downgrade | Argus | Buy → Hold |
| 2025-08-04 | Downgrade | Stifel | Buy → Hold |
| 2025-08-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Baxter International stock heads into the open after a modest gain - ad-hoc-news.de
Intravenous Immunoglobulin Market Size Worth USD 30.83 Billion by 2035, Growing at 7.49% CAGR – SNS Insider - GlobeNewswire Inc.
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Transcript : Baxter International Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 12 - marketscreener.com
Baxter at Wells Fargo conference: growth improves as turnaround continues By Investing.com - Investing.com UK
A Look at Baxter International Inc (BAX) After 3.8% Decline -- G - GuruFocus
Baxter International stock trades sideways as technical signals flag limited near-term upside - ad-hoc-news.de
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International stock holds steady as investors await next earnings signal - ad-hoc-news.de
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure - Yahoo Finance
Human Albumin Market Report Analyzes Growth Factors, Challenges, and Market Dynamics - openPR.com
Don't Ignore The Insider Selling In Abeona Therapeutics - simplywall.st
Baxter International Inc. (BAX) Stock Analysis: Exploring Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Baxter International stock holds steady as investors focus on recent restructuring and earnings prof - ad-hoc-news.de
ETFs Investing in Baxter International Inc. Stocks - TradingView
Before Mark Walter’s companies faced inquiries, he kept a low profile and built loyalty - Los Angeles Times
Two IV Saline Recalls Within Days Cite Iron Oxide and Fiberglass Particles Found Inside Sealed Hospital Bags - Medical Daily
IV bags recalled in MD over potential fiberglass contamination - Maryland Daily Record
Baxter International Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Baxter International stock holds steady as investors digest latest quarterly figures - ad-hoc-news.de
Jerry Flansburg Obituary (2026)International Falls, MNRainy Lake Gazette - Legacy obituary
Baxter International CEO Andrew P. Hider Surrenders Shares for Tax Withholding on September 2, 2026 - Kalkine Media
Baxter (NYSE: BAX) exec ends with 29,164 shares after tax move - Stock Titan
Recalls issued for possible fiberglass particles in IV solutions made at WNC facility: FDA - WLOS
Baxter International stock gains after strong Q2 figures - ad-hoc-news.de
Taiwan's Best Companies to Work for in Asia Transformed a Talent Crisis into a Strategic Advantage - PR Newswire
Baxter International stock holds gains as recalls and earnings shape sentiment - AD HOC NEWS
Baxter International stock could double, Tom Hayes says - Yahoo Finance
FDA recalls saline bags in 14 states over possible fiberglass contamination - thecooldown.com
Baxter International stock steadies as recall news meets mixed analyst view - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Exploring a 9.94% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Baxter: This Turnaround Stock Is Up and Still 38% Undervalued - Morningstar
2 drugs recalled over potential fiberglass, steel presence - WGN-TV
Saline bags recalled in 14 states due to potential fiberglass contamination - kare11.com
Fiberglass in IV saline? Texas among states included in recall - MySA
Baxter International Inc. (BAX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Saline used in IV injections recalled nationwide due to fiberglass - FOX 8 News
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Several Baxter vaccine, solution lots recalled due to potential ‘particulate matter’ - WFMJ
Licensable picture: Baxter International CEO and President Robert Parkinson Jr. looks over at the families of the victims of Heparin reactions testifying during a House Energy and Commerce subcommittee hearing on Heparin imports from China on Capitol Hill - reutersconnect.com
Baxter Recalls an IV Nutrition Solution After Stainless Steel Particles Turned Up Inside the Sterile Bag - Medical Daily
Baxter Issues Voluntary Nationwide Recall for One Lot of Anticoagulant Sodium Citrate Solution Due to Potential Presence of Particulate Matter - USA Today
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with Potential 9.06% Upside - DirectorsTalk Interviews
Baxter International stock holds steady as new CFO joins and analyst estimates shift - Ad-hoc-news.de
Zacks Research Issues Negative Estimate for BAX Earnings - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in Baxter International Inc. $BAX - MarketBeat
Baxter International (BAX) Taps John Rogers As Chief Financial Officer - Sahm
Baxter hires new CFO with visa contingency - CFO Dive
Baxter hires CFO from Smith & Nephew - MedTech Dive
1,435,460 Shares in Baxter International Inc. $BAX Acquired by Tocqueville Asset Management L.P. - MarketBeat
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.44%
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):